These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 5994431)
1. [Dangers of MAO inhibitors]. Paufique L; Charleux J; Aimard G; Lequin M; Michaud MP Bull Soc Ophtalmol Fr; 1966; 66(5):560-2. PubMed ID: 5994431 [No Abstract] [Full Text] [Related]
2. [Electroretinographic study of a case of monoamine oxidase inhibitor poisoning]. Ardouin M; Urvoy M; Raoul T; Herve MC Bull Soc Ophtalmol Fr; 1967 Oct; 67(10):920-4. PubMed ID: 5621016 [No Abstract] [Full Text] [Related]
6. [Toxic optic neuritis due to IMAO]. Sourdille J Gaz Med Fr; 1965 Apr; 72(8):1629-32. PubMed ID: 5830675 [No Abstract] [Full Text] [Related]
7. Drugs having a toxic effect on the optic nerve. Leibold JE Int Ophthalmol Clin; 1971; 11(2):137-57. PubMed ID: 4338111 [No Abstract] [Full Text] [Related]
8. [The eye and drugs]. Payrau P Eur J Toxicol; 1971; 4(1):60-6. PubMed ID: 4937281 [No Abstract] [Full Text] [Related]
10. The hepatic injury of monoamine oxidase inhibitors. Zimmerman HJ; Ishak KG J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504 [No Abstract] [Full Text] [Related]
11. [Adverse effects and complications of antidepressive chemotherapy]. Loo H; Bousser MG Cah Med; 1972 Sep; 13(10):777-94. PubMed ID: 4566411 [No Abstract] [Full Text] [Related]
12. [Bilateral optic neuritis with sudden onset occurring in an atherosclerotic subject, a heavy smoker, poisoned by an monoamine oxidase inhibitor (MAOI)]. Kalt M Bull Soc Ophtalmol Fr; 1965 Mar; 65(3):194-201. PubMed ID: 5830357 [No Abstract] [Full Text] [Related]
13. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction. van Amsterdam J; Talhout R; Vleeming W; Opperhuizen A Life Sci; 2006 Oct; 79(21):1969-73. PubMed ID: 16884739 [TBL] [Abstract][Full Text] [Related]
14. [Effect of various antidepressive agents on brain monoamine oxidase activity]. Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732 [TBL] [Abstract][Full Text] [Related]
15. [Monoamine oxidase inhibitors and pressor response to dietary amines]. Tipton KF Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors. Hadizadeh F; Ghodsi R Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243 [TBL] [Abstract][Full Text] [Related]
18. An open multicenter study of the efficacy of MDL 72,974A, a monoamine oxidase type B (MAO-B) inhibitor, in Parkinson's disease. Myllylä VV; Sotaniemi KA; Aasly J; Sjaastad O; Rinne U; McIntyre T; Cremer G Adv Neurol; 1993; 60():676-80. PubMed ID: 8420209 [No Abstract] [Full Text] [Related]
19. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related]
20. [2 fatal cases of reaction due to the combination of MAO inhibitors and tricyclic antidepressants. Medico-legal aspects]. Cagliesi Cingolani R; Bencini A Riv Patol Nerv Ment; 1982; 103(1):21-31. PubMed ID: 7170585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]